Literature DB >> 11266958

Experimental study of tacrolimus immunosuppression on the mode of administration: efficacy of constant intravenous infusion avoiding C(max).

M Ishibashi1, K Yoshida, S Ozono, Y Hirao, K Takahashi, Y Kawamura, K Ohara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11266958     DOI： 10.1016/s0041-1345(00)02142-4

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Once- versus twice-daily tacrolimus: are the formulations truly equivalent?

Authors:  Katherine A Barraclough; Nicole M Isbel; David W Johnson; Scott B Campbell; Christine E Staatz
Journal:  Drugs       Date:  2011-08-20       Impact factor: 9.546

2.  Cognitive Evaluation in Liver Transplant Patients Under Calcineurin Inhibitor Maintenance Therapy.

Authors:  Nils Heits; Dalibor Keserovic; Niclas Mund; Nicola Ehmke; Alexander Bernsmeier; Alexander Hendricks; Rainer Gunther; Karsten Witt; Thomas Becker; Felix Braun
Journal:  Transplant Direct       Date:  2017-03-28

3.  Early Versus Late Conversion From Immediate to Prolonged-Release Tacrolimus After Renal Transplantation: Clinical Effects and Treatment Costs.

Authors:  Luís Mendonça; Hugo Diniz; José Silvano; Sofia Marques; Susana Sampaio; Manuel Pestana
Journal:  Transplant Direct       Date:  2018-12-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.